BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6132461)

  • 1. Metabolism and mutagenicity of N-nitrosohexamethyleneimine and its hydroxylated derivatives.
    Hecker LI; Saavedra JE; Andrews AW
    Teratog Carcinog Mutagen; 1983; 3(1):9-17. PubMed ID: 6132461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of nitrosamines to mutagens by rat and rabbit nasal, lung and liver S-9 homogenates.
    Dahl AR
    Adv Exp Med Biol; 1986; 197():367-72. PubMed ID: 2945408
    [No Abstract]   [Full Text] [Related]  

  • 3. The quantitative structure-activity relationship approach to the mutagenicity of N-nitrosomethylaniline compounds.
    Jinno K
    Mutat Res; 1984; 141(3-4):141-3. PubMed ID: 6392878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
    Rumruen K; Pool BL
    Mutat Res; 1984; 140(2-3):147-53. PubMed ID: 6379440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro formation and properties of beta- and gamma-hydroxy-N-nitrosohexamethyleneimine.
    Hecker LI; Saavedra JE
    Carcinogenesis; 1980; 1(12):1017-25. PubMed ID: 11272106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man.
    Mori Y; Yamazaki H; Toyoshi K; Maruyama H; Konishi Y
    Mutat Res; 1986 May; 160(3):159-69. PubMed ID: 3960034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
    Hecker LI; Saavedra JE; Farrelly JG; Andrews AW
    Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species.
    Alldrick AJ; Rowland IR
    Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W; Andrews AW
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity of several pancreatic carcinogenic derivatives of N-nitrosodipropylamine in the Ames assay.
    Wislocki P; Gingell R
    Mutat Res; 1980 Mar; 77(3):215-9. PubMed ID: 6991919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of donor age on the levels of activity of rat, hamster and human liver S9 preparations in the Salmonella mutagenicity assay.
    Raineri R; Andrews AW; Poiley JA
    J Appl Toxicol; 1986 Apr; 6(2):101-8. PubMed ID: 3700958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
    Negishi T; Hayatsu H
    Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of microsomal inducer pretreatment on the in vitro alpha-hydroxylation and mutagenicity of N-Nitrosopyrrolidine in rat and hamster liver.
    McCoy GD; Hecht SS; McCoy EC
    Environ Mutagen; 1982; 4(3):221-30. PubMed ID: 7047158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters.
    Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M
    Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of some derivatives of dipyrido[1,2-a:3',2'-d]imidazoles in Salmonella typhimurium with metabolic activation by rat liver and small intestine subcellular fractions.
    N'Goy K; Saint-Ruf G; de Meester C
    Mutat Res; 1985; 156(1-2):53-9. PubMed ID: 3889627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species difference in the metabolic activation of phenacetin by rat and hamster liver microsomes.
    Nohmi T; Yoshikawa K; Nakadate M; Ishidate M
    Biochem Biophys Res Commun; 1983 Feb; 110(3):746-52. PubMed ID: 6404262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species specificity in the metabolism of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine to mutagens by isolated rat and hamster hepatocytes.
    Mangino MM; Hollenberg PF; Scarpelli DG
    Cancer Res; 1987 Sep; 47(18):4776-81. PubMed ID: 3113724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic potentiation of the rat hepatic microsome mediated mutagenicity of benzidine.
    Smith JN; Ioannides C
    Mutagenesis; 1987 May; 2(3):205-9. PubMed ID: 3325744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of beta-oxidized N,N,-di-n-propylnitrosamine derivatives in S. typhimurium mediated by rat and hamster tissues.
    Camus A; Bertram B; Krüger FW; Malaveille C; Bartsch H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):293-302. PubMed ID: 136104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.